EN
HI
Aspira Pathlab & Diagnostics Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
6453.00
Market Cap
63.24 CR
LTQ@LTP
1@63.90
ATP
63.75
Var Margin
100 %
Circuit Range
49.16-73.72
Delivery %
98.87 %
Value
4.11 L
ASM/GSM
No
Market Lot
1
Summary
Aspira Pathlab & Diagnostics share price stands at ₹63.9 at 8 May, 2026 | 14:58. The stock Aspira Pathlab & Diagnostics intraday movement has stayed between ₹60.10 and ₹64.00, while on a 52-week basis it has fluctuated from ₹49.00 to ₹81.00.
In terms of trading activity, Aspira Pathlab & Diagnostics has recorded a volume of 6453 shares. The Aspira Pathlab & Diagnostics has a market cap of ₹10293000. The stock’s Average Traded Price (ATP) stands at ₹6375, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 6390.
The Aspira Pathlab & Diagnostics operates within a circuit range of ₹49.16-73.72 – ₹49.16-73.72, with a Value of ₹4.11 L. The Delivery Percentage for the day is 98.87%. Additionally, Aspira Pathlab & Diagnostics currently falls under the No framework, and trades with a market lot size of 1.
Aspira Pathlab & Diagnostics Fundamentals
View MoreP/E Ratio
27.42
P/B Ratio
5.2
Div. Yield
0
Sector P/E
56.71
Sector P/B
-15.78
Sec. Div. Yield
1.86
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 62.94
Resistance
First Resistance
65.87
Second Resistance
70.31
Third Resistance
73.24
Support
First Support
58.5
Second Support
55.57
Third Support
51.13
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
Aspira Pathlab & Diagnostics News
Aspira Pathlab & Diagnostics Ltd - 540788 - Updates on Open Offer
Acquirers, through Aftertrade Broking, announced an open offer for Aspira Pathlab & Diagnostics Limited to acquire 26% of its equity shares at ₹55 per share. This cash offer values the stake at approximately ₹14.76 crores and will increase the acquirers' combined holding to 32.73% post-offer. The independent directors consider the offer price fair.
Apr 13 2026 16:04:00
Aspira Pathlab & Diagnostics Ltd - 540788 - Updates on Open Offer
Aspira Pathlab & Diagnostics' Independent Director Committee (IDC) recommends the open offer for 26,76,180 equity shares at ₹55/share as fair and reasonable, in line with SEBI (SAST) Regulations, 2011. The offer represents 26% of the company's fully paid-up equity share capital and is managed by Aftertrade Broking Private Limited.
Apr 10 2026 19:04:00
About Aspira Pathlab & Diagnostics
NSE : 0
BSE : 540788
ISIN : INE500C01017
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 63.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 27.42. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 5.2. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 56.71 & -15.78 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 63.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 81.00 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
